Register entry
Apellis Pharmaceuticals, Inc.
- Registered sites
- 0
- Drug products
- 2
- Live patents
- 24
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
24Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| EMPAVELI | PEGCETACOPLAN | Nov 2027 |
| EMPAVELI | PEGCETACOPLAN | Dec 2027 |
| EMPAVELI | PEGCETACOPLAN | Jan 2033 |
| EMPAVELI | PEGCETACOPLAN | Aug 2033 |
| EMPAVELI | PEGCETACOPLAN | Nov 2033 |
| EMPAVELI | PEGCETACOPLAN | Apr 2038 |
| EMPAVELI | PEGCETACOPLAN | Dec 2038 |
| EMPAVELI | PEGCETACOPLAN | Dec 2038 |
| SYFOVRE | PEGCETACOPLAN | Oct 2026 |
| SYFOVRE | PEGCETACOPLAN | Apr 2027 |
| SYFOVRE | PEGCETACOPLAN | Nov 2027 |
| SYFOVRE | PEGCETACOPLAN | Dec 2027 |
| SYFOVRE | PEGCETACOPLAN | Jan 2033 |
| SYFOVRE | PEGCETACOPLAN | Aug 2033 |
| SYFOVRE | PEGCETACOPLAN | Nov 2033 |
| SYFOVRE | PEGCETACOPLAN | Oct 2036 |
| SYFOVRE | PEGCETACOPLAN | Feb 2037 |
| SYFOVRE | PEGCETACOPLAN | Dec 2038 |
Catalogue
Marketed products
2Showing 2 of 2.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Empaveli | Pegcetacoplan | INJECTION, SOLUTION | NDA |
| Syfovre | Pegcetacoplan | INJECTION, SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.